This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Human medicines European public assessment report (EPAR): Leqembi, Lecanemab, St...
Summary of opinion: Supemtek Tetra (previously Supemtek), 27/02/2025 Positive
Human medicines European public assessment report (EPAR): Vyjuvek, beremagene ge...
Human medicines European public assessment report (EPAR): Lynozyfic, linvoseltam...
Combination of cystic fibrosis medicines to treat patients with rare mutations
Summary of opinion: Calquence, 27/02/2025 Positive
Human medicines European public assessment report (EPAR): Pelgraz Paediatric, pe...
Human medicines European public assessment report (EPAR): Trabectedin Accord, tr...
First topical gene therapy treatment for dystrophic epidermolysis bullosa
Human medicines European public assessment report (EPAR): Rilonacept FGK Represe...